Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Utility of Flexion-extension MRI to Reveal Occult Cervical Spondylotic Compression in Those with Suspected Inflammatory or Undifferentiated Myelopathies
Autoimmune Neurology
C16 - Clinical Approach to Myelopathy (2:48 PM-2:55 PM)
P3 - Poster Session 3 (12:00 PM-1:00 PM)
065

Cervical spondylotic myelopathy can be misdiagnosed as inflammatory myelitis leading to unnecessary immunotherapy and delayed definitive surgical treatment.

To describe the utility of flexion-extension MRI in inflammatory and undifferentiated myelopathies with spinal cord T2-hyperintensity.

Mayo Clinic patients were identified retrospectively from 12/31/2012-10/24/2023. Inclusion criteria were: 1) Age ≥18 years; 2) Myelopathy; 3) Flexion-extension cervical spine MRI available; 4) Spinal cord T2-hyperintensity on MRI.

Ninety patients that underwent flexion-extension MRI were included, and the median age was 58 years (range, 30-81) with 47 (52%) of male sex. Cervical spondylotic myelopathy was the final diagnosis in 65 (85% had insidious onset; 12% had accompanying reverse Lhermitte’s phenomenon). In 55/65 (85%) the diagnosis of cervical spondylotic myelopathy was aided by evidence of increased cord compression during flexion-extension MRI (worse in extension, 47[85%]; worse in flexion, 4[7.5%]; both, 4[7.5%]). In 3/58 (5%) patients, positional cord compression occurred on Flexion-Extension MRI, but an alternative cause of myelopathy was found (Multiple sclerosis, 2; progressive lateral sclerosis, 1).  Prior to the Flexion-Extension MRI being undertaken, 26/65 (40%) with cervical spondylotic myelopathy were initially assigned alternative diagnoses and 19 (29%) received immunotherapy for presumed inflammatory myelitis. The median delay to diagnosis in these patients was 15 months (range, 0.5-155). The median length of cord T2-hyperintensity on sagittal sequences was 1 vertebral segment (range, 1-5) and 33/53 (62%) had accompanying enhancement. In 46/65 (71%) decompressive surgery was undertaken at Mayo Clinic and 29/46 (63%) reported improvement, 14/46 (30%) noted stability and 3/46 (6%) worsened.

Cervical spondylotic myelopathy with spinal cord T2-hyperintensity was frequently misdiagnosed as myelitis in this series often leading to unnecessary immunotherapy and delayed definitive treatment. Flexion-Extension MRI is a straightforward MRI technique which can show positional cord compression and allow more rapid diagnosis and earlier treatment of unrecognized cervical spondylotic myelopathy.

Authors/Disclosures
Santiago Martinez Sosa, MBBS
PRESENTER
Dr. Martinez Sosa has nothing to disclose.
Eoin P. Flanagan, MBBCh, FAAN (Mayo Clinic) The institution of Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from Viela Bio. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities.
Karl Krecke Karl Krecke has nothing to disclose.